Abstract
[reaction: see text] In this, the first of two letters, we outline the use of the pyrrolidine-5,5-trans-lactam template to design small, neutral, mechanism-based inhibitors of hepatitis C NS3/4A protease. The hitherto unreported reaction of the acyl iminium ion precursor 4 with dialkyl-substituted silyl ketene acetals (e.g., 8b) is described. Compound 12b, with a spirocyclobutyl P1 substituent and a cyclopropylacyl substituent on the lactam nitrogen, has a k(obs)/I of 400 M(-)(1) s(-)(1) and demonstrates activity in a replicon cell-based surrogate HCV assay.
MeSH terms
-
Cell Line
-
Drug Design
-
Drug Stability
-
Hepacivirus / drug effects
-
Hepacivirus / enzymology*
-
Humans
-
Lactams / chemical synthesis*
-
Lactams / chemistry
-
Molecular Structure
-
Protease Inhibitors / chemical synthesis*
-
Protease Inhibitors / chemistry
-
Protease Inhibitors / pharmacology*
-
Pyrrolidines / chemical synthesis*
-
Pyrrolidines / chemistry
-
Serine Endopeptidases / metabolism*
-
Viral Nonstructural Proteins / antagonists & inhibitors*
-
Viral Nonstructural Proteins / metabolism
Substances
-
Lactams
-
NS3 protein, hepatitis C virus
-
Protease Inhibitors
-
Pyrrolidines
-
Viral Nonstructural Proteins
-
Serine Endopeptidases